antiinfective drug

A general term indicating either an antibiotic (or antibacterial), an antifungal or an antiviral agent, as well as the sulfonamides.

Mentioned in ?

References in periodicals archive ?

Redx Pharma, Liverpool: Delivering new antiinfective drug candidates.

HOW GOVERNMENT GRANT WINNERS WILL SPEND THEIR CASH

The 'snapshots' we have taken of one of these enzymes, together with the new inhibitor itself, can provide very valuable guidance for the development of new anti-cancer and antiinfective drug candidates.

A NEW family of molecules [...]

to develop and deploy new chemical information tools in antiinfective drug discovery.

Synthematix Announces Ongoing Chemistry Collaboration With Cubist Pharmaceuticals

a privately held company, today announced the formation of an antiinfective drug discovery collaboration.

Cubist Pharmaceuticals and Syrrx Announce Drug Discovery Collaboration

Collaboration Focuses on VITA(TM) Target Validation and Antiinfective Drug

Cubist Pharmaceuticals Announces Extension of Research and License Agreement with Novartis Pharma

Cubist will receive a payment of $500,000 for the delivery of a validated target and a high-throughput screening assay for antiinfective drug discovery.

Cubist Pharmaceuticals Achieves Milestone From Novartis Collaboration

We believe this acquisition will accelerate the achievement of our strategic goal of attaining world leadership and a global presence in antiinfective drug discovery, development and commercialization," said Scott M.

Cubist Pharmaceuticals, Inc. to Acquire TerraGen Discovery Inc

This agreement demonstrates our commitment to rapidly developing a leadership position in the research field of antiinfective drug discovery," said Paul Herrling, Ph.

Cubist Pharmaceuticals Licenses VITA(TM) Technology to Novartis Pharma AG for Antiinfective Drug Discovery

The data to be presented demonstrates the validation of a target for antiinfective drug discovery by the regulated inhibition of the target in a pathogen during a systemic infection.

Cubist Pharmaceuticals Describes New VITA(TM) Technology for Enabling Genomics for Drug Discovery

Cubist will receive a milestone payment for the delivery of a fourth novel, validated target and high-throughput screening assay for antiinfective drug discovery.

Cubist Pharmaceuticals Announces Achievement of Fourth Milestone in Novartis Antiinfective Drug Discovery Collaboration

Enanta's antiinfective drug development is expected to enter human clinical testing in late 2002.

Enanta Pharmaceuticals Licenses SciQuest's SelectSite e-Procurement Solution

Keith brings a very impressive background in antiinfective drug discovery to Cubist Pharmaceuticals.

Cubist Hires Vice President, Drug Discovery From Hoffman-LaRoche; Elects Dr. David Martin, Jr. to Board of Directors and Promotes Dr. Francis Tally